[recIndex] (https://github.com/johnnybender/adastandards2016/blob/master/index/recIndex.md)

### **If noninsulin monotherapy at maximum tolerated dose does not achieve or maintain the A1C target after 3 months, add a second oral agent, a glucagon-like peptide 1 receptor agonist, or basal insulin.**
* Unique ID: rec133
* Evidence Letter: A
* Category Name: PHARMACOLOGIC THERAPY FOR TYPE 2 DIABETES
* Page: S65
* Feasible: Yes
* Type: Rec
* Comments: 

#### Race Codes:

Description | Codes
----------- | -----


#### Ethnicity Codes:

Description | Codes
----------- | -----
|

#### ICD-9 Codes:

Description | Codes
----------- | -----
|

#### ICD-10 Codes:

Description | Codes
----------- | -----
|

#### ICD-10 PCS Codes:

Description | Codes
----------- | -----
|

#### SNOMED Codes:

Description | Codes
----------- | -----
|

#### CPT Codes:

Description | Codes
----------- | -----
|

#### HCPCS Codes:

Description | Codes
----------- | -----
|

#### LOINC Codes:

Description | Codes
----------- | -----
|

#### CVX Codes:

Description | Codes
----------- | -----
|

#### AHFS Medication Class:

Description | Codes
----------- | -----
|

#### RxNorm:

Description | Codes
----------- | -----
|

#### Miscellaneous Codes:

Description | Dictionary | Codes
----------- | ---------- | -----
|

#### Modules:

Module |
------ |
|

#### Implementation:
